DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Thursday reported a loss of $2.7 million in its second quarter.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of 24 cents.
The biopharmaceutical posted revenue of $260,100 in the period. Its adjusted revenue was $260,000.
In the final minutes of trading on Thursday, the company's shares hit 59 cents. A year ago, they were trading at $3.10.